Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on October 16, 2025
MDLifespan Founder Dr. Paul Savage to Speak at Eudēmonia 2025: Surviving a Toxic World with Therapeutic Plasma Exchange
WEST PALM BEACH, FL, UNITED STATES, October 16, 2025 /EINPresswire.com/ -- MDLifespan (www.mdlifespan.com), a Public Benefit Corporation pioneering advanced detoxification protocols will be present at Eudēmonia 2025, a global summit uniting thought …
In-Home Care Services Improve Daily Living in Clermont, FL
CLERMONT, FL, UNITED STATES, October 16, 2025 /EINPresswire.com/ -- Families searching for compassionate, dependable support for their aging loved ones have a trusted resource in Comfort Keepers of Clermont. Led by local owner Tracy Kelley, Comfort …
Comfort Keepers of Fort Myers Highlights the Benefits of In-Home Senior Care for Local Families
FORT MYERS, FL, UNITED STATES, October 16, 2025 /EINPresswire.com/ -- Comfort Keepers of Fort Myers, led by General Manager Dawn Pudlin, continues to make a difference in the lives of seniors by offering compassionate, uplifting care that helps older …
Infotel Announces Solution Compatibility for Its DB/IQ Suite for IBM’s Latest Releases of z17 Hardware and z/OS 3.2
Infotel announces its solution suite for IBM Db2®, DB/IQ, is now compatible with IBM’s z17 hardware platform and also IBM’s latest OS release, version 3.2. Infotel SA (ENX:INF) TAMPA, FL, UNITED STATES, October 16, 2025 /EINPresswire.com/ -- Infotel, a …
Disc Medicine Announces Receipt of FDA Commissioner’s National Priority Voucher (CNPV) for Bitopertin in Erythropoietic Protoporphyria (EPP)
Disc is seeking accelerated approval of bitopertin for patients aged 12 years and older with EPP The CNPV program is designed to reduce the drug application review process to 1-2 months WATERTOWN, Mass., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc …
VISIUM and Lovell Partner to Expand VA and DoD Access to Far-UVC Technology
Collaboration delivers VA-approved Far-UVC technology to federal healthcare systems, advancing safer environments for those who serve. PENSACOLA, FL, UNITED STATES, October 16, 2025 /EINPresswire.com/ -- Lovell® Government Services and VISIUM, the …
Lexeo Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants
NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO) (the “Lexeo”), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, today announced that it has commenced an …
Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details
WAYNE, Pa., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its third quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, November 6, 2025. To …
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
AUDUBON, Pa., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the third quarter ended September 30, 2025 after the market close on Thursday, November …
atai Life Sciences Announces Proposed Public Offering of Common Shares
NEW YORK and AMSTERDAM, Oct. 16, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company focused on transforming the treatment of mental health disorders, today announced the commencement …
atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression
Breakthrough Therapy designation recognizes the potential of BPL-003 to deliver substantial improvement over existing therapies for patients with treatment-resistant depression FDA designation follows previously announced Phase 2b topline data which showed …
WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective October 21, 2025
Hangzhou, China, Oct. 16, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and …
LifeStance to Host Third Quarter 2025 Earnings Conference Call on November 6, 2025
SCOTTSDALE, Ariz., Oct. 16, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, will issue its third quarter 2025 earnings release before the market opens on …
Lite Strategy Celebrates 14th Anniversary of Litecoin, Taps Institutional Signals Ahead of 2026
SAN DIEGO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Lite Strategy, Inc. (NASDAQ: LITS) (“Lite Strategy” or “LITS”), the first U.S.-listed public company to adopt Litecoin as its primary reserve asset, joins the digital asset community in celebrating the 14th …
Seer to Report Third Quarter 2025 Financial Results on November 6, 2025
REDWOOD CITY, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial results for the third quarter 2025 on Thursday, November …
RxSight, Inc. to Feature Live Learning Sessions at American Academy of Ophthalmology 2025 Annual Meeting
ALISO VIEJO, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced it will be featured in …
Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication, Upcoming Data Releases, and Corporate Update
Prioritization of refractory rheumatoid arthritis (RA) as lead indication for AlloNK® development FDA Fast Track Designation received for AlloNK in refractory RA, representing the first drug candidate in the deep B-cell depleting category to receive this …
I-Mab Announces Intention to Undertake Strategic Transformation to Global Biotech Platform, to Pursue Hong Kong IPO, and Rebrand as NovaBridge Biosciences
New business model reflects strategic transition to a global biotech platform focused on business development and translational clinical development to accelerate access to innovative medicines for patients worldwide Intention to pursue a Hong Kong initial …